Similar articles

• Molecular genetics and T cells in autoimmunity.

  Stastny P, Myers LK, Nuñez G, Hoover ML, Capra JD, Ball EJ. Stastny P, et al. Ann N Y Acad Sci. 1986;475:12-23. doi: 10.1111/j.1749-6632.1986.tb20852.x. Ann N Y Acad Sci. 1986. PMID: 2878637 No abstract available.
• Molecular aspects of HLA class II and some autoimmune diseases.

  Lepage V, Lamm LU, Charron D. Lepage V, et al. Eur J Immunogenet. 1993 Jun;20(3):153-64. doi: 10.1111/j.1744-313x.1993.tb00106.x. Eur J Immunogenet. 1993. PMID: 8338813 Review. No abstract available.
• HLA class II disease associations: molecular basis.

  Charron D. Charron D. J Autoimmun. 1992 Apr;5 Suppl A:45-53. doi: 10.1016/0896-8411(92)90018-l. J Autoimmun. 1992. PMID: 1503635 Review. No abstract available.
• HLA and diseases: involvement of more than one HLA-linked determinant of disease susceptibility.

  Scholz S, Albert E. Scholz S, et al. Immunol Rev. 1983;70:77-88. doi: 10.1111/j.1600-065x.1983.tb00710.x. Immunol Rev. 1983. PMID: 6832799 No abstract available.
• Mutagenesis and expression of putative class II susceptibility genes: a "reverse immunogenetics" approach to analysis of HLA and disease.

  Nepom GT. Nepom GT. Autoimmunity. 1990;7(2-3):189-99. doi: 10.3109/08916939008993391. Autoimmunity. 1990. PMID: 1716479 Review.